FDA Approves Lupin’s Generic Equivalent of Ultram ER for Chronic Pain

The FDA has approved Lupin’s generic equivalent of Ortho-McNeil’s Ultram ER tablets to treat chronic pain, according to a Lupin news release.

Advertisement

 

Lupin’s tramadol hydrochloride extended release tablets come in strengths of 100 mg, 200 mg and 300 mg.


Related Articles on FDA Drug Approvals:

FDA Approves Tapentadol for Chronic Pain

Drug Counselors Urge Tighter Controls for Hydrocodone

Boca Pharmacal Receives FDA Approval of Generic Drug for Pain


At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.